Sonnet biotherapeutics announces participation in the ef hutton annual global conference

Minneapolis, minnesota--(newsfile corp. - may 3, 2024) - sonnet biotherapeutics holdings, inc. (nasdaq: sonn), a biopharmaceutical company developing innovative targeted biologic drugs, will be participating in the ef hutton annual global conference, which will take place on may 15, 2024 at the plaza hotel in new york. pankaj mohan, ph.d.

SONN Ratings Summary

SONN Quant Ranking